Shields P G
Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD 20892.
J Occup Med. 1993 Jan;35(1):34-41.
Carcinogenesis is a multistage process that results from the interaction of carcinogenic exposures, cellular macromolecules (eg, DNA), and endogenous mutational mechanisms. Involved in these processes are metabolic activation and detoxification of chemical carcinogens, genetic sequences of protooncogenes and tumor suppressor genes, and DNA repair, among others. Each of these vary widely among individuals and can be associated with increased cancer risk. Cytochrome P4501A1, P4502E1 and N-acetyl transferase 2 are examples of enzymes involved in the metabolic activation of potential environmental carcinogens such as polycyclic aromatic hydrocarbons, benzene, and aromatic amines, respectively. Germ-line mutations in these genes are common and associated with abnormal enzymatic function that are mechanistically related to quantitative changes in binding of carcinogens to DNA. Allelic frequencies for these mutations vary among different racial and ethnic populations and may explain, in part, differences in cancer rates. Risk assessments attempt to predict cancer rates in humans using mathematical models that are often based upon limited experimental data. They do not generally incorporate the numerous stages of carcinogenesis or interindividual variation. Thus, sensitive and resistant populations are not sufficiently considered. This limits the accuracy of currently applied risk assessment models.
致癌作用是一个多阶段过程,它源于致癌暴露、细胞大分子(如DNA)和内源性突变机制之间的相互作用。参与这些过程的有化学致癌物的代谢活化和解毒、原癌基因和肿瘤抑制基因的遗传序列以及DNA修复等。这些因素在个体之间差异很大,并且可能与癌症风险增加有关。细胞色素P4501A1、P4502E1和N-乙酰转移酶2分别是参与潜在环境致癌物(如多环芳烃、苯和芳香胺)代谢活化的酶的例子。这些基因中的种系突变很常见,并且与异常的酶功能相关,这些酶功能在机制上与致癌物与DNA结合的定量变化有关。这些突变的等位基因频率在不同种族和民族群体中有所不同,并且可能部分解释了癌症发病率的差异。风险评估试图使用通常基于有限实验数据的数学模型来预测人类的癌症发病率。它们通常没有纳入致癌作用的众多阶段或个体间差异。因此,没有充分考虑敏感人群和抗性人群。这限制了当前应用的风险评估模型的准确性。